Cellectis
CLLS
#7753
Rank
S$0.46 B
Marketcap
S$4.51
Share price
0.28%
Change (1 day)
104.38%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: S$0.46 Billion

As of February 2026 Cellectis has a market cap of S$0.46 Billion. This makes Cellectis the world's 7753th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.46 B-24.78%
2025S$0.61 B212.93%
2024S$0.19 B-32.85%
2023S$0.29 B121.95%
2022S$0.13 B-74.67%
2021S$0.51 B-69.3%
2020S$1.68 B67.75%
2019S$1.00 B0.57%
2018S$0.99 B-25.83%
2017S$1.34 B53.83%
2016S$0.87 B-42.31%
2015S$1.51 B162.5%
2014S$0.57 B582.1%
2013S$84.83 M

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Cellectis was reported to be:

S$0.32 Billion
by Nasdaq info icon info icon
S$0.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
S$104.55 B 22,619.18%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
S$2.11 B 359.12%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
S$1.71 B 271.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
S$0.58 B 26.93%๐Ÿ‡บ๐Ÿ‡ธ USA